Drugs / MGCND00EP1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04406948 | May 2024 | epilepsy | MGC Pharmaceuticals d.o.o | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MGCND00EP1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04406948 ↗ |
| Route | Oral | “oral administration” NCT04406948 ↗ |